Hearscape
← Devices & Neurotechnology
Details checkedStrong evidenceCheckedtrial

Envoy Medical Acclaim Cochlear Implant

Also known as: Acclaim, Acclaim Cochlear Implant, Fully implanted Acclaim cochlear implant

Envoy Medical

Primary source
Company
Envoy Medical
Program Type
Device
Modality
Cochlear/Auditory Implant
Stage
Phase 2/3
Status
Active
Target Gene
—
Route / Mode
Fully implantable neuro-otologic device
Confidence
93%
Status Confidence
Status confirmed
Evidence Strength
Strong evidence
Last Reviewed
2026-05-31
Geography
United States
Population
adult, post-lingual, profound
Trial IDs
1
Mechanism

A fully implanted cochlear implant intended to use an implantable microphone and eliminate the need for externally worn components.

Indications
Hearing LossSensorineural Hearing Loss
Notes

Most visible fully implanted cochlear implant program in U.S. development; strategically important because it targets a step-change in convenience and continuous hearing use.

Evidence & Sources
3 structured sources
company
Supports: canonicalName, company, mechanism, status, route, notes
Open
clinicaltrials
Supports: stage, status, trialIds, geography
IDs: NCT06699797
Open
company
Supports: keyEvents, notes
Open
Key Events
2022-06-21
Envoy announced FDA IDE approval for the Acclaim early feasibility study
2025-10-29
Envoy reported enrollment progress in the Acclaim pivotal trial
Clinical Trials (1)
NCT06699797
Related Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Cochlear Nucleus Nexa System
Company: Cochlear · Cochlear/Auditory Implant · Marketed
MED-EL SYNCHRONY Cochlear Implant System
Company: MED-EL · Cochlear/Auditory Implant · Marketed
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed
Cochlear Nucleus Profile Plus CI600 Series Implants
Company: Cochlear · Cochlear/Auditory Implant · Marketed